Geisinger Health System-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Geisinger Health System - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014014
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Geisinger Health System (GHS) is an integrated health services organization that provides medical and surgical specialties and sub-specialties, and related health services. It offers a range of medical services for patients suffering from diseases related to cardiology, ENT, gastroenterology, gynecology, cancer, obstetrics, ophthalmology, orthopedics and pediatrics, infectious diseases, and others. The organization also provides Life Flight regional helicopter ambulance services. It operates through several hospital campuses. GHS serves residents across several counties in central, south-central and northeast Pennsylvania; and southern New Jersey at AtlantiCare. The organization also offers medical education, research and community services. GHS is headquartered in Danville, Pennsylvania, the US.

Geisinger Health System – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Geisinger Health System, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Geisinger Health System, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Geisinger Health System, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Geisinger Health System, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Geisinger Health System, Medical Devices Deals, 2011 to YTD 2017 10
Geisinger Health System, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Geisinger Health System, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
xG Health Solutions Raises US$40 Million In Venture Financing 12
Partnerships 13
Geisinger Enters into Agreement with Boehringer Ingelheim 13
DNAnexus Enters Into Co-Development Agreement With Geisinger Health System And University of California 14
Merger 16
Geisinger Health And Lewistown Hospital Complete Merger 16
Geisinger Health System And Holy Spirit Health System To Merge 17
Acquisition 18
Geisinger Health System Acquires Viewmont Health Associates 18
RegionalCare Hospital Partners and Billings Clinic to Acquire Community Medical Center 19
Geisinger Health System Completes Acquisition Of Community Medical Center 20
Geisinger Health System – Key Competitors 21
Geisinger Health System – Key Employees 22
Geisinger Health System – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 25
Recent Developments 26
Strategy And Business Planning 26
Nov 14, 2017: Geisinger launches National Precision Health Initiative 26
Corporate Communications 27
Jul 14, 2017: Dr. Sandra Culbertson named Chair of Geisinger’s Women’s Health 27
Jun 27, 2017: Geisinger names Karen Murphy Executive Vice President and Chief Innovation Officer 28
Sep 16, 2016: Adam Buchanan named to American Board of Genetic Counseling 29
Mar 25, 2016: Rosemary Leeming, M.D., named GMC chief medical officer 30
Legal and Regulatory 31
Mar 22, 2016: Geisinger Health System receives accreditation from the Association for the Accreditation of Human Research Protection Programs 31
Government and Public Interest 32
Jun 20, 2017: Geisinger’s ADMI official recruitment site for autism research; awarded grant to help in major new genetic study 32
Jun 13, 2017: MyCode Community Health Initiative hits another milestone; 150,000 signed up to largest health system sequencing project 33
May 25, 2017: MyCode study could lead to new drugs to prevent coronary artery disease 34
Dec 07, 2016: Geisinger study finds opioids not helpful in treating chronic pain 35
Nov 29, 2016: Open-heart surgery patients notified of potential infection risk 36
Jul 19, 2016: Pennsylvania Department of Health Provides Update on Medical Marijuana Program Implementation Process; Urges Physician Participation 37
Mar 21, 2016: Geisinger receives grant to install medication take-back boxes in Lycoming County pharmacies 38
Mar 04, 2016: Geisinger physician participating in PCORI-sponsored study on patient-centered kidney care 39
Feb 16, 2016: Geisinger study published in The American Journal of Managed Care demonstrates Value-Based 40
Feb 02, 2016: GenomeFIRST awarded $400K grant to bring genomic information into patients’ care plans 41
Jan 27, 2016: Geisinger researchers identify 17 genes related to developmental brain disorders 42
Other Significant Developments 43
Jan 05, 2017: Geisinger Health System President and CEO to reveal new community health initiative at StartUp Health Festival 43
Nov 02, 2016: Geisinger joins national effort to improve diabetes management 44
Oct 13, 2016: Geisinger selected to join the national Precision Medicine Initiative 45
Jul 27, 2016: Geisinger community benefit reaches $580 million for FY 15 46
Jul 19, 2016: Geisinger Health System joins initiative to increase colorectal cancer screening rates 47
Apr 25, 2016: Geisinger’s MyCode genomic study hits 100K recruits; Goal now set at 250K 48
Apr 18, 2016: Enrollment in Geisinger’s Text U 4 Better Health messaging program just got easier 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Geisinger Health System, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Geisinger Health System, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Geisinger Health System, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Geisinger Health System, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Geisinger Health System, Deals By Therapy Area, 2011 to YTD 2017 9
Geisinger Health System, Medical Devices Deals, 2011 to YTD 2017 10
Geisinger Health System, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
xG Health Solutions Raises US$40 Million In Venture Financing 12
Geisinger Enters into Agreement with Boehringer Ingelheim 13
DNAnexus Enters Into Co-Development Agreement With Geisinger Health System And University of California 14
Geisinger Health And Lewistown Hospital Complete Merger 16
Geisinger Health System And Holy Spirit Health System To Merge 17
Geisinger Health System Acquires Viewmont Health Associates 18
RegionalCare Hospital Partners and Billings Clinic to Acquire Community Medical Center 19
Geisinger Health System Completes Acquisition Of Community Medical Center 20
Geisinger Health System, Key Competitors 21
Geisinger Health System, Key Employees 22
Geisinger Health System, Other Locations 24
Geisinger Health System, Subsidiaries 24
Geisinger Health System, Joint Venture 25

★海外企業調査レポート[Geisinger Health System-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Teva Pharmaceutical Industries Ltd (TEVA)-医療機器分野:企業M&A・提携分析
    Summary Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company off …
  • Scapa Group plc (SCPA):企業の財務・戦略的SWOT分析
    Scapa Group plc (SCPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • The Middleby Corporation (MIDD):企業の財務・戦略的SWOT分析
    The Middleby Corporation (MIDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Lisega SE:企業の戦略的SWOT分析
    Lisega SE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Banco di Desio e della Brianza SpA:企業の戦略・SWOT・財務分析
    Banco di Desio e della Brianza SpA - Strategy, SWOT and Corporate Finance Report Summary Banco di Desio e della Brianza SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • OpGen Inc (OPGN):製薬・医療:M&Aディール及び事業提携情報
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • The Boston Consulting Group:企業の戦略的SWOT分析
    The Boston Consulting Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • University of Maryland Medical Center Corp:企業の戦略的SWOT分析
    University of Maryland Medical Center Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Patel Engineering Ltd:企業の戦略・SWOT・財務情報
    Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Strikeforce Technologies Inc (SFOR):企業の財務・戦略的SWOT分析
    Summary Strikeforce Technologies Inc (Strikeforce) is a technology company that offers cybersecurity solutions. The company offers products such as protectID, guardedID and mobiletrust. Strikeforce offers services such as information technology services, key logging and mobile security solutions, am …
  • James Latham Plc (LTHM):企業の財務・戦略的SWOT分析
    James Latham Plc (LTHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Bioneer Corp (064550):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioneer Corp (Bioneer) is a molecular diagnostic company that develops and produces molecular research and molecular diagnostic products and instruments. The company’s major molecular research products include DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and r …
  • Becton Dickinson and Co (BDX)-製薬・医療分野:企業M&A・提携分析
    Summary Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instrument. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management …
  • PRA Health Sciences Inc (PRAH):企業の財務・戦略的SWOT分析
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides outsourced clinical development and data solution services. The company offers asset valuation, regulatory and drug development consulting, risk-based monitoring, site identification and selection, medical …
  • Hengyuan Refining Company Bhd (HENGYUAN):企業の財務・戦略的SWOT分析
    Hengyuan Refining Company Bhd (HENGYUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Chembio Diagnostic Inc (CEMI):医療機器:M&Aディール及び事業提携情報
    Summary Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP). Its DPP technol …
  • Synopsys, Inc.:企業の戦略・SWOT・財務情報
    Synopsys, Inc. - Strategy, SWOT and Corporate Finance Report Summary Synopsys, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Evertec Inc (EVTC):企業の財務・戦略的SWOT分析
    Summary Evertec Inc (Evertec) is a technology and communication company that offers transaction processing services. The company’s services include payment processing, merchant acquiring and business process management. Its payment processing services comprise card issuing and acquiring processing; …
  • Shuwen Biotech Co Ltd:企業の製品パイプライン分析2018
    Summary Shuwen Biotech Co Ltd (Shuwen Biotech) is a medical equipment company. The company develops diagnostic products and services for disease prevention, diagnosis and personalized medicine. It offers in-vitro diagnostic (IVD) kits for oncology and pregnancy-related conditions. Shuwen Biotech dev …
  • Emgesa SA ESP-エネルギー分野:企業M&A・提携分析
    Summary Emgesa SA ESP (Emgesa), a subsidiary of Enel, is an energy utility that generates and trades electricity. The company produces power from hydro, coal, and oil and gas; and procures energy from generator and trader agents in the wholesale market. It owns thermal stations: Cartagena and Martin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆